Getz K - Search Results

1

Quantifying Site Burden to Optimize Protocol Performance.

Florez M, Smith Z, Olah Z, Martin M, Getz K. Florez M, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 Mar;58(2):347-356. doi: 10.1007/s43441-023-00602-5. Epub 2024 Jan 8. Ther Innov Regul Sci. 2024. PMID: 38191957

2

Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.

Levitan B, Getz K, Eisenstein EL, Goldberg M, Harker M, Hesterlee S, Patrick-Lake B, Roberts JN, DiMasi J. Levitan B, et al. Among authors: getz k. Ther Innov Regul Sci. 2018 Mar;52(2):220-229. doi: 10.1177/2168479017716715. Epub 2017 Jul 17. Ther Innov Regul Sci. 2018. PMID: 29714515 Free PMC article.

3

Insights and Best Practices for Planning and Implementing Patient Advisory Boards.

Anderson A, Getz KA. Anderson A, et al. Ther Innov Regul Sci. 2018 Jul;52(4):469-473. doi: 10.1177/2168479017720475. Epub 2017 Jul 25. Ther Innov Regul Sci. 2018. PMID: 29714530

4

Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations.

Lamberti MJ, Wilkinson M, Harper B, Morgan C, Getz K. Lamberti MJ, et al. Among authors: getz k. Ther Innov Regul Sci. 2018 Sep;52(5):572-578. doi: 10.1177/2168479017751403. Epub 2018 Jan 11. Ther Innov Regul Sci. 2018. PMID: 29714558

5

The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies.

Lamberti MJ, Kubick W, Awatin J, McCormick J, Carroll J, Getz K. Lamberti MJ, et al. Among authors: getz k. Ther Innov Regul Sci. 2018 Nov;52(6):778-783. doi: 10.1177/2168479018764662. Epub 2018 Mar 28. Ther Innov Regul Sci. 2018. PMID: 29714579

6

Baseline Assessment of the Evolving 2017 eClinical Landscape.

Wilkinson M, Young R, Harper B, Machion B, Getz K. Wilkinson M, et al. Among authors: getz k. Ther Innov Regul Sci. 2019 Jan;53(1):71-80. doi: 10.1177/2168479018769292. Epub 2018 Apr 26. Ther Innov Regul Sci. 2019. PMID: 29714600

7

New Benchmarks Characterizing Growth in Protocol Design Complexity.

Getz KA, Campo RA. Getz KA, et al. Ther Innov Regul Sci. 2018 Jan;52(1):22-28. doi: 10.1177/2168479017713039. Epub 2017 Jun 23. Ther Innov Regul Sci. 2018. PMID: 29714620

8

Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing.

DiMasi JA, Smith Z, Getz KA. DiMasi JA, et al. Clin Ther. 2018 Jun;40(6):963-972. doi: 10.1016/j.clinthera.2018.04.011. Epub 2018 May 11. Clin Ther. 2018. PMID: 29755005

9

Evaluating the Completeness of ClinicalTrials.gov.

Stergiopoulos S, Getz KA, Blazynski C. Stergiopoulos S, et al. Ther Innov Regul Sci. 2019 May;53(3):307-317. doi: 10.1177/2168479018782885. Epub 2018 Jul 26. Ther Innov Regul Sci. 2019. PMID: 30048602

10

Generational Value Differences Affecting Public Perceptions of and Willingness to Participate in Clinical Trials.

Nelson AM, Martin IG, Getz KA. Nelson AM, et al. Ther Innov Regul Sci. 2015 Nov;49(6):940-946. doi: 10.1177/2168479015583727. Ther Innov Regul Sci. 2015. PMID: 30222373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page